Protego Ventures Closes $125M Defense Tech Fund I

A battlefield can prove that a defense system works under pressure. It cannot complete the export review, integration work, procurement process, production planning, or contract renewal that turns that system into a durable global company. Protego Ventures has reached the final close of Protego Ventures Fund I at $125M to finance that transition for early-growth Israeli defense companies. Announced on September 29, 2026, the fund plans to invest $5M-$15M per company across autonomous systems, artificial intelligence, cybersecurity, sensors, drones, resilient navigation, and critical-infrastructure technology.

The close gives Protego a specialist pool of capital at a moment when defense startups are attracting more attention from venture investors and allied governments. The harder question is whether capital can help operationally tested technology move through the institutional machinery required to reach repeatable customers. Protego is betting that its network and operating experience can make that handoff faster and more legible.

Protego Ventures Closes Fund I at $125M

Protego's September 29 announcement identifies the event as the final close of Fund I, not a target, launch, or interim close. The vehicle is focused on early-growth Israeli defense companies, a stage where founders may already have working technology and operational evidence but still need capital, customer access, and procurement support to scale globally.

Independent reporting adds an important accounting detail. TechCrunch reported that Fund I will generally invest $5M-$15M per company. It also reported that executives from Ares Management, rather than Ares Management itself, were among Protego's largest backers and supplied a $30M limited-partner commitment.

That distinction matters. Fund announcements often compress a management firm, its investment vehicle, its LPs, and recognizable institutions into one convenient sentence. Protego Ventures is the management firm. Fund I is the $125M vehicle. The disclosed Ares connection is to executives investing as LPs, according to TechCrunch, not a direct investment by Ares Management.

Why Protego Stopped Below Its Earlier Target

Protego's website has described the fund as a $150M defense vehicle, while the final announcement says $125M. The difference reflects an earlier target versus the final close, not an extra $25M that disappeared from the accounting.

Lital Leshem told TechCrunch that Protego chose to stop at $125M because XTEND's public listing could make the portfolio company a meaningful driver of Fund I's economics. A larger fund would spread that potential return across a bigger capital base. That is Protego's stated rationale, not audited proof of future performance, but it is a more revealing decision than the usual race to announce the largest possible vehicle.

The choice puts concentration at the center of the story. A specialist fund can benefit when one early investment compounds quickly, yet concentration also raises the importance of entry price, ownership, follow-on decisions, and the performance of the rest of the portfolio. Protego has kept those economics private, so the public record supports the strategy, not a forecast.

The Team Behind the Defense Investment Strategy

Lital Leshem is Protego's Co-Founder and Managing Partner. Protego's official biography identifies Leshem as a former Carbyne co-founder, former Frontier Resource Group partner, and Major (Res.) with 11 years of military and intelligence experience.

Lee Moser is Co-Founder and General Partner. Protego's team page says Moser remains Managing Partner of AnD Ventures and previously served as chief of staff to Israeli Ambassador Michael Oren in Washington, DC. The broader Protego team adds experience in military digital transformation, defense strategy, finance, partnerships, and investor relations.

That mix explains the firm's pitch. Defense founders do not only need an investor who can assess software, autonomy, or sensors. They need help understanding government customers, security requirements, procurement pathways, strategic partners, and the difference between a successful field deployment and a scalable commercial program.

Portfolio Evidence From XTEND, ASIO, Prisma, and Rilian

Protego describes XTEND as its first portfolio company and says it led the autonomous-systems company's $70M Series B. XTEND has since listed on the New York Stock Exchange under the ticker XTND, giving Protego a visible early test of its thesis that Israeli defense technology can move from operational use to public-market scale.

Fund I's disclosed portfolio also includes ASIO, Prisma Photonics, and Rilian. Protego presents those companies as examples across contested-environment navigation, critical-infrastructure sensing, autonomous systems, and agentic cyber defense. Specific deployment and customer claims in Protego's release remain company-reported, but the portfolio makes the mandate more concrete than a generic label such as defense technology.

The common thread is the translation of technical capability into systems that can operate in constrained, high-consequence environments. That translation requires more than a product demo. It requires reliability, integration, procurement literacy, manufacturing discipline, and access to customers whose timelines and risk standards differ sharply from ordinary enterprise software.

What the $125M Close Signals for Defense Tech

Protego's close arrives as venture capital becomes more comfortable with defense and national-security technology. Recent conflicts have increased demand for autonomy, sensing, cyber defense, infrastructure protection, and faster deployment, while governments are looking beyond traditional contractors for technology that can be fielded and updated more quickly.

That attention can create its own blind spots. Operational urgency does not remove the need for diligence, and battlefield validation does not automatically establish repeatable revenue, exportability, or allied procurement fit. The companies that endure will have to preserve technical speed while learning the institutional work that turns urgent adoption into durable programs.

Protego says Fund II will broaden the firm's reach into early-growth US defense companies. For Fund I, the immediate task is already substantial: help Israeli founders turn field evidence into procurement credibility, production capacity, and customer relationships that survive beyond the first urgent deployment. The $125M close gives Protego the capital to test whether specialist venture support can carry more companies across that distance.